Tempest Therapeutics TPST
NASDAQ TPST
$0.82 -0.09 (-9.61%)
As of: Sep 10, 2026 · 3:07 PM EDT

Tempest Therapeutics (TPST) EBT Margin (QoQ) (2015 - 2018)

Analysis

Tempest Therapeutics (TPST) EBT Margin (QoQ) (2015 - 2018) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Krystal Biotech 10.20 Bn 9.35 Bn 112.79 Mn
2 CRISPR Therapeutics AG 5.03 Bn 5.03 Bn -
3 Iovance Biotherapeutics 3.64 Bn 3.35 Bn 55.72 Mn
4 Legend Biotech 3.54 Bn 2.58 Bn 251.50 Mn
5 uniQure 2.98 Bn 2.98 Bn 5.49 Mn
6 Beam Therapeutics 2.54 Bn 2.54 Bn -
7 Precigen 2.38 Bn 2.38 Bn 52.17 Mn
8 Sarepta Therapeutics 2.16 Bn 1.37 Bn 251.87 Mn
9 Vericel 1.93 Bn 1.77 Bn 56.40 Mn
10 Tempest Therapeutics 3.42 Mn 2.62 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2018 -81,558.00
Jun 30, 2018 149,012.00
Mar 31, 2018 -166,593.00
Dec 31, 2017 737,308.00
Sep 30, 2017 492,738.00
Jun 30, 2017 199,405.00
Mar 31, 2017 -490,213.00
Dec 31, 2016 -898,076.00
Sep 30, 2016 5,220.00
Jun 30, 2016 505,349.00
Mar 31, 2016 -177,748.00
Dec 31, 2015 1.08 Mn
Sep 30, 2015 3.44 Mn
Jun 30, 2015 5.64 Mn